Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-cell Renal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06949215
What this trial is testing

68Ga-NYM096 PET/ CT for the Detection of ccRCC in Presurgical Patients With Complex Cystic Renal Leision

Who this might be right for
ccRCCComplex Renal Cyst
Peking Union Medical College Hospital 70
Early research (Phase 1)Ended earlyNCT02628535
What this trial is testing

Safety Study of MGD009 in B7-H3-expressing Tumors

Who this might be right for
MesotheliomaBladder CancerMelanoma+10 more
MacroGenics 67
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Not applicableStudy completedNCT05745142
What this trial is testing

Go Back Into Records and Observe How People With Metastatic Renal Cell Carcinoma (mRCC) Who Received a Medicine Called Sunitinib Responded to This Medicine.

Who this might be right for
Carcinoma, Renal CellClear-cell Metastatic Renal Cell Carcinoma
Pfizer 376
Testing effectiveness (Phase 2)Study completedNCT03013335
What this trial is testing

Nivolumab in Patients With Metastatic Renal Cell Carcinoma Who Have Progresses During or After Prior Systemic Anti-angiogenic Regimen

Who this might be right for
Metastatic Renal Cell Carcinoma
UNICANCER 730
Testing effectiveness (Phase 2)Looking for participantsNCT07187778
What this trial is testing

Phase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal Cell Carcinoma (BLAZE)

Who this might be right for
Clear Cell Renal Cell Carcinoma
M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT05155033
What this trial is testing

Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma

Who this might be right for
Metastatic MelanomaAdvanced Locoregional MelanomaMetastatic Renal Cell Carcinoma+1 more
National Cancer Institute (NCI) 78
Testing effectiveness (Phase 2)UnknownNCT04644432
What this trial is testing

Individualized Treatment Strategy for Patients With Metastatic Non-clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell CarcinomaKidney NeoplasmUrologic Neoplasms+1 more
Herlev and Gentofte Hospital 30
Early research (Phase 1)Study completedNCT01472081
What this trial is testing

Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)

Who this might be right for
Renal Cell CarcinomaClear-cell Metastatic Renal Cell Carcinoma
Bristol-Myers Squibb 194
Post-approval studies (Phase 4)Ended earlyNCT00930345
What this trial is testing

Biological, Pathological and Imagery Markers in the First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Assistance Publique - Hôpitaux de Paris 33
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07488572
What this trial is testing

Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Clear Cell Renal Cell Carcinoma
Sun Yat-sen University 60
Testing effectiveness (Phase 2)Study completedNCT02917772
What this trial is testing

Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal CellClear-cell Metastatic Renal Cell Carcinoma
AIO-Studien-gGmbH 200
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Early research (Phase 1)Looking for participantsNCT07128680
What this trial is testing

Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell CarcinomaMetastatic Clear Cell Renal Cell Carcinoma+3 more
City of Hope Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT00126503
What this trial is testing

Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Chromophobe Renal Cell CarcinomaClear Cell Renal Cell CarcinomaPapillary Renal Cell Carcinoma+3 more
National Cancer Institute (NCI) 73
Testing effectiveness (Phase 2)Looking for participantsNCT05361720
What this trial is testing

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more
Vanderbilt-Ingram Cancer Center 54
Large-scale testing (Phase 3)Looking for participantsNCT06750419
What this trial is testing

89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study

Who this might be right for
Clear Cell Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited 82
Testing effectiveness (Phase 2)UnknownNCT03341845
What this trial is testing

Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC

Who this might be right for
Renal Cell Carcinoma
The Netherlands Cancer Institute 40
Testing effectiveness (Phase 2)Study completedNCT03548467
What this trial is testing

Evaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Locally Advanced or Metastatic Solid Tumours
Nykode Therapeutics ASA 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06574412
What this trial is testing

Cardenilimab Combined With Lenvatinib in Patients With Perioperative Resectable Clear Cell Renal Cell Carcinoma.

Who this might be right for
Resectable Clear Cell Carcinoma of the Kidney
The First Hospital of Jilin University 30
Next Page